Awareness, treatment and control of hypertension in Denmark. The Inter99 study

Blood Pressure

Volumn 16, Issue 5, 2007, Pages 312-319

  Sehestedt, Thomas ^a,b   Ibsen, Hans ^b   Jørgensen, Torben ^a  

^a Research Centre for Prevention and Health   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Awareness; Control; Cross sectional study; Hypertension; Lifestyle; Predictor; Risk factor; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DENMARK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FEMALE; GENDER; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; AWARENESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DENMARK; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 35348830316     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050701428307     Document Type: Article

References (28)

1. World Health Organisation, International Society of Hypertension Writing Group (2003) 2003 WHO/ISH statement on management of hypertension. J Hypertens, 21, pp. 1983-1992.
2. Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360, pp. 1903-1913.
3. Levi, F., Lucchini, F., Negri, E. and La Vecchia, C. (2002) Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart, 88, pp. 119-124.
4. Kearney, P. M., Whelton, M., Reynolds, K., Whelton, P. K. and He, J. (2004) Worldwide prevalence of hypertension: A systematic review. J Hypertens, 22, pp. 11-19.
5. Hajjar, I. and Kotchen, T. A. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, 290, pp. 199-206.
6. Jørgensen, T., Borch-Johnsen, K., Thomsen, F., Ibsen, H., Glümer, C. and Pisinger, C. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: Baseline results Inter99. Eur J Cardiovasc Prevention Rehab, 10, pp. 377-386.
7. Toft, U., Kristoffersen, L., Lau, C., Borch-Johnsen, K. and Jørgensen, T. (2007) The Dietary Quality Score: Validation and association with cardiovascular risk factors. The Inter99 study. Eur J Clin Nutr, 61, pp. 420-430.
8. Knight, E. L., Rhonda, L. B., Wang, P. S., Glynn, R. J., Mogun, J. and Avorn, J. (2001) Predictors of uncontrolled hypertension in ambulatory patients. Hypertension, 38, pp. 809-819.
9. Esposti, E. D., Martino, M. D., Sturani, A., Russo, P., Dradi, C., Falcinelli, S. and Buda, S. (2004) Risk factors for uncontrolled hypertension in Italy. J Hum Hypertens, 18, pp. 207-213.
10. Hyman, D. J. and Pavlik, V. N. (2001) Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med, 345, pp. 479-486.
11. Shah, S. and Cook, D. G. (2001) Inequalities in the treatment and control of hypertension: Age, social isolation and lifestyle are more important than economic circumstances. J Hypertens, 19, pp. 1333-1340.
12. Guidelines Committee (2003) 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 21, pp. 1011-1053.
13. Wolf-Maier, K., Richard, Cooper, R. S., Kramer, H., Banegas, J. R. and Giampaoli, S. (2004) Hypertension treatment and control in five European Countries, Canada, and the United States. Hypertension, 43, pp. 10-17.
14. Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., Faire, U. and Fyhrquist, F. (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet, 359, pp. 1004-1010.
15. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA, 288, pp. 2981-2997.
16. Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G. and Caulfield, M. (2005) for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet, 366, pp. 895-906.
17. Andersen, L. B., Vestbo, J., Juel, K., Bjerg, A. M., Keiding, N. and Jensen, G. (1998) The Copenhagen Center for Prospective Population Studies. A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city and the entire country. Eur J Epidemiol, 14, pp. 579-585.
18. Green, B. B., Kaplan, R. C. and Psaty, B. M. (2003) How do minor changes in the definition of blood pressure control affect the reported success of hypertension treatment?. Am J Manag Care, 9, pp. 219-224.
19. Meisssner, I., Whisnant, J. P., Sheps, S. G., Schwartz, G. L., O'Fallon, W. M. and Covalt, J. L. (1999) Detection and control of high blood pressure in the community. Hypertension, 34, pp. 466-471.
20. Godwin, M., Delva, D., Seguin, R., Casson, I., MacDonald, S. and Birtwhiste, R. (2004) Relationship between blood pressure measurements recorded on patients' charts in family physician' offices and subsequent 24 hour ambulatory blood pressure monitoring. BMC Cardiovasc Disord, 12, p. 2.
21. Longo, D., Dorigatti, F. and Palatini, P. Paolo (2005) Masked hypertension in adults. Blood Press Monit, 10, pp. 307-310.
22. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure Education Program Coordination Committee (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med, 157, pp. 2413-2446.
23. Gwenn, E. C., Nelemans, P., Schouten, J. S. and Prins, M. H. (2004) Facts and fiction of poor compliance as a cause of inadequate blood pressure control: A systematic review. J Hypertens, 22, pp. 1849-1855.
24. Berlowitz, D. R., Ash, A. S., Hickey, E. C., Friedman, R. H., Glickman, M. and Kader, B. (1998) Inadequate management of blood pressure in a hypertensive population. N Engl J Med, 339, pp. 1957-1963.
25. Oliveria, S. A., Lapuerta, P., McCarthy, B., L'Iitalien, G. J., Berlowitz, D. R. and Asch, S. M. (2002) Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med, 162, pp. 413-420.
26. Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M. and Gallina, D. L. (2001) Clinical inertia. Ann Intern Med, 135, pp. 825-834.
27. Lloyd-Jones, D. M., Evans, J. C., Larson, M. G. and Levy, D. (2002) Treatment and control of hypertension in the community - A prospective analysis. Hypertension, 40, pp. 640-646.
28. Bang, L. E., Bruun, N. E., Cristensen, K. L. and Svendsen, T. L. (2004) Hypertension, behandlingsvejledning 2004